Literature DB >> 18278466

Changes of TXA2 and PGI2 during postoperative hypertensive crisis in patients with hypertensive intracerebral hemorrhage.

Zhi Wang1, Chao Wang, Weiguang Zhang, Laizang Wang, Ting Lei.   

Abstract

In order to explore the changes and the roles of TXA2 and PGI2 during postoperative hypertensive crisis in patients with hypertensive intracerebral hemorrhage, 31 cases subject to craniotomy were divided into three groups: group A, 9 patients with postoperative hypertensive crisis; group B, 13 patients without postoperative hypertensive crisis; and group C, 9 patients without history of hypertension and hypertensive intracerebral hemorrhage. TXA2, TXB2, 6-keto-PGF1 alpha and PGI2 were measured after operation in the three groups respectively. The postoperative blood pressure in group A, including SBP and DBP, was elevated more obviously than that in the other two groups. TXA2 and PGI2 in group A were significantly higher than those in other two groups (P<0.01). Moreover, the ratio of TXB2 to 6-keto-PGF1 alpha in group A was significantly higher than that in other two groups (P<0.05). The increase of TXA2 and the relative inadequacy of prostacyclin, especially 6-keto-PGF1 alpha, may play roles in the postoperative hypertensive crisis. And the increased value of TXB2 to 6-keto-PGF1 alpha could provide the basis for diagnosis of postoperative hypertensive crisis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18278466     DOI: 10.1007/s11596-008-0122-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin.

Authors:  Ke-He Ruan; Hui Deng; Shui-Ping So
Journal:  Biochemistry       Date:  2006-11-28       Impact factor: 3.162

Review 2.  Management of hypertensive crises: the scientific basis for treatment decisions.

Authors:  J D Blumenfeld; J H Laragh
Journal:  Am J Hypertens       Date:  2001-11       Impact factor: 2.689

Review 3.  Advances in the pathogenesis and management of hypertensive crisis.

Authors:  Hiren P Patel; Mark Mitsnefes
Journal:  Curr Opin Pediatr       Date:  2005-04       Impact factor: 2.856

Review 4.  The diagnosis and management of hypertensive crises.

Authors:  J Varon; P E Marik
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

Review 5.  Current concepts in the management of hypertensive crisis: emergencies and urgencies.

Authors:  D J Rosenow; E Russell
Journal:  Holist Nurs Pract       Date:  2001-07       Impact factor: 1.000

6.  Hypertensive crisis profile. Prevalence and clinical presentation.

Authors:  José Fernando Vilela Martin; Erika Higashiama; Evandro Garcia; Murilo Rizzatti Luizon; José Paulo Cipullo
Journal:  Arq Bras Cardiol       Date:  2004-08-17       Impact factor: 2.000

Review 7.  Hypertensive emergencies. Etiology and management.

Authors:  Meryem Tuncel; Venkata C S Ram
Journal:  Am J Cardiovasc Drugs       Date:  2003       Impact factor: 3.571

Review 8.  Hypertensive crises: challenges and management.

Authors:  Paul E Marik; Joseph Varon
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

  8 in total
  1 in total

1.  The Protective Effect of Aspirin against Myocardial Hypertrophy in Rats.

Authors:  Xiaolong Wu; Minghui Wei; Haifeng Zhang; Xiaomei Fan; Xiaochen Ma; Jiaming Liu; Mingming Xue
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.